Basic Information
Flexus Biosciences, Inc. was founded in 2013 as a privately held biopharmaceutical company dedicated to the creation, development, and commercialization of novel cancer therapies through the innovative application of untapped immunological insights.
Flexus Biosciences, Inc.
California,United States of America
15~50 people
January 01, 2013
ken.dominski@bms.com